The estimated Net Worth of Richard A. Richieri is at least $637 millier dollars as of 12 July 2024. Mr. Richieri owns over 1,469 units of Avid Bioservices Inc stock worth over $368,445 and over the last few years he sold CDMO stock worth over $44,879. In addition, he makes $223,558 as Chief Operations Officer at Avid Bioservices Inc.
Sign up
Mr. Richieri CDMO stock SEC Form 4 insiders trading
Richard has made over 11 trades of the Avid Bioservices Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 1,469 units of CDMO stock worth $15,571 on 12 July 2024.
The largest trade he's ever made was exercising 7,799 units of Avid Bioservices Inc stock on 28 June 2023 worth over $82,669. On average, Richard trades about 2,448 units every 27 days since 2023. As of 12 July 2024 he still owns at least 34,759 units of Avid Bioservices Inc stock.
You can see the complete history of Mr. Richieri stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Richard Richieri biography
Richard A. Richieri serves as Chief Operations Officer of the Company. Mr. Richieri has over 25 years of biopharmaceutical industry experience spanning the areas of drug discovery, CGMP operations, contract manufacturing and process development. Mr. Richieri previously spent 15 years with Avid Bioservices and its former parent company, Peregrine Pharmaceuticals, including the role of senior vice president of manufacturing. During that time, he was instrumental in launching, building and growing Avid's CDMO business and helping the company diversify its production capabilities. He spent the past five years serving as an advisor and acting head of biologics production for Syngene International, a global discovery, development and manufacturing organization serving the pharmaceutical industry.
What is the salary of Richard Richieri?
As the Chief Operations Officer of Avid Bioservices Inc, the total compensation of Richard Richieri at Avid Bioservices Inc is $223,558. There are 7 executives at Avid Bioservices Inc getting paid more, with Nicholas Stewart Green B.Sc., MBA having the highest compensation of $1,545,522.
How old is Richard Richieri?
Richard Richieri is 51, he's been the Chief Operations Officer of Avid Bioservices Inc since 2019. There are 12 older and 2 younger executives at Avid Bioservices Inc. The oldest executive at Avid Bioservices Inc is Joseph Carleone, 74, who is the Independent Non-Executive Chairman of the Board.
What's Richard Richieri's mailing address?
Richard's mailing address filed with the SEC is 14191, Myford Road, Walnut, Tustin, Orange County, California, 92780, United States.
Insiders trading at Avid Bioservices Inc
Over the last 7 years, insiders at Avid Bioservices Inc have traded over $1,839,814 worth of Avid Bioservices Inc stock and bought 460,748 units worth $3,573,760 . The most active insiders traders include Gregory Sargen, Nicholas Stewart Green et Mark R Bamforth. On average, Avid Bioservices Inc executives and independent directors trade stock every 16 days with the average trade being worth of $107,028. The most recent stock trade was executed by Richard A. Richieri on 12 July 2024, trading 1,469 units of CDMO stock currently worth $15,571.
What does Avid Bioservices Inc do?
avid bioservices, a subsidiary of peregrine pharmaceuticals, inc. (nasdaq: pphm), is a unique contract manufacturing organization ("cmo") partner dedicated to the development and production of monoclonal antibodies, recombinant proteins and enzymes produced in mammalian cell culture. our extensive experience at all stages of development enables us to provide comprehensive development, manufacturing and support services to navigate a biologic from concept to commercialization.
What does Avid Bioservices Inc's logo look like?
Complete history of Mr. Richieri stock trades at Avid Bioservices Inc
Avid Bioservices Inc executives and stock owners
Avid Bioservices Inc executives and other stock owners filed with the SEC include:
-
Nicholas Stewart Green B.Sc., MBA,
Pres, CEO & Director -
Mark Ziebell,
Vice President, General Counsel, Corporate Secretary -
Daniel R. Hart,
Chief Financial Officer -
Daniel Hart,
Chief Financial Officer -
Richard Hancock,
Director -
Mark R. Ziebell J.D.,
VP, Gen. Counsel & Corp. Sec. -
Catherine Mackey,
Independent Director -
Richard Richieri,
Chief Operations Officer -
Joseph Carleone,
Independent Non-Executive Chairman of the Board -
Gregory Sargen,
Independent Director -
Patrick Walsh,
Independent Director -
Mark Bamforth,
Independent Director -
Stephanie Diaz,
Investor Relations / Corporate Communications -
Timothy Compton,
Chief Commercial Officer -
Nicholas Green,
President, Chief Executive Officer, Director -
Prof. Alan J. Schroit,
Medical & Scientific Advisor -
Dr. Harold F. Dvorak,
Medical & Scientific Advisor -
Tracy L. Kinjerski,
VP of Bus. Operations -
Dr. Shelley P. M. Fussey,
VP of Intellectual Property -
Matthew Kwietniak,
Chief Commercial Officer -
Lorna Larson,
Sr. Director of HR -
Richard Richieri,
Chief Operations Officer -
Joel Mc Comb,
Director -
Roger J. Lias,
President & CEO -
Esther M. Alegria,
Director -
Jeanne Thoma,
Director -
Matthew R. Kwietniak,
Chief Commercial Officer